Drugs / CKD-4101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01016626 | Jul → Aug 2009 | — | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-4101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01016626 ↗ |
| Known as | Mycophenolate Mofetil | “CKD-4101 (Mycophenolate Mofetil) Tablet” NCT01016626 ↗ |
| Route | Oral | “500mg/tablet, PO” NCT01016626 ↗ |